FDA Webview

A unique analytical online news service covering FDA regulation of pharmaceuticals, medical devices, biologics and veterinary medicines

[FDA Webview @FDAWEB]

@RoguePOTUSStaff Keep up the good work. Any word on who POTUS has tapped to head FDA.

[FDA Webview @FDAWEB]

#FDA aims to increase data integrity detection. https://t.co/1LhumuB8I0

[FDA Webview @FDAWEB]

#FDA denies AstraZeneca crestor petition-- begins approving generics
https://t.co/TVcVjOtRj4

[FDA Webview @FDAWEB]

#FDA Oversight Lacking with Questionable Data ... https://t.co/1LhumujxQs

[FDA Webview @FDAWEB]

former #FDA official pleads guilty in insider trading case. https://t.co/1LhumujxQs

[FDA Webview @FDAWEB]

#FDA lab safety in question. https://t.co/1LhumujxQs

[FDA Webview @FDAWEB]

Drug company looking to settle government probe over its sales
activities. #pharma $FDA https://t.co/1LhumujxQs

[FDA Webview @FDAWEB]

#FDA draft guide on 3D-printed devices - https://t.co/1LhumujxQs

[FDA Webview @FDAWEB]

New #FDA Guidance on Drug Proprietary Names -- https://t.co/1LhumujxQs #pharma #CDER

[FDA Webview @FDAWEB]

#FDA requiring new standards for e-submissions of clinical study data... https://t.co/1LhumujxQs

[FDA Webview @FDAWEB]

#CDER says it will require packaging design changes for eye drop bottles #FDA... https://t.co/1LhumujxQs

[FDA Webview @FDAWEB]

#FDA Medical Devices-- Analysis of 2015 Inspection Observations and Warning Letter Cites... https://t.co/1LhumujxQs

[FDA Webview @FDAWEB]

New white paper recommends 11 drug quality metrics for #FDA to use during inspections... https://t.co/1LhumujxQs

[FDA Webview @FDAWEB]

#FDA staff devoted to biosimilars increased significantly (55%) last year, costs also shot up. https://t.co/1LhumujxQs

[FDA Webview @FDAWEB]

researchers find merit to #CDRH requiring shorter trials with enhanced post-approval surveillance... #FDA https://t.co/1LhumujxQs

[FDA Webview @FDAWEB]

Another senior #FDA official resigns... https://t.co/1LhumujxQs

[FDA Webview @FDAWEB]

ICYMI... #FDA safety review of Gilead Sciences 2014-approved Zydelig (idelalisib) after study deaths reported... https://t.co/1LhumujxQs

[FDA Webview @FDAWEB]

#FDA safety review of Gilead Sciences 2014-approved Zydelig (idelalisib) after study deaths reported... https://t.co/1LhumujxQs

[FDA Webview @FDAWEB]

Another top FDA official leaving the agency... https://t.co/1LhumujxQs

[FDA Webview @FDAWEB]

#FDA Warning Letter summaries... https://t.co/1LhumujxQs